Loading data
XERSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 291.85 m USD | 203.07 m USD | 163.91 m USD | 110.25 m USD | 49.59 m USD |
| Research and development expense | 31.17 m USD | 25.56 m USD | 22.34 m USD | 20.97 m USD | 25.16 m USD |
| Selling, general and administrative expense | 182.37 m USD | 163.48 m USD | 146.1 m USD | 137.75 m USD | 125.72 m USD |
| Operating profit | 24.9 m USD | -33.65 m USD | -44.01 m USD | -81.94 m USD | -115.16 m USD |
| Interest expense | — | — | 26.6 m USD | 14.1 m USD | 7.18 m USD |
| Profit before tax | 554 k USD | -57.1 m USD | -63.5 m USD | -96.08 m USD | -122.73 m USD |
| Income tax expense | 0 USD | -2.27 m USD | -1.25 m USD | -1.42 m USD | 0 USD |
| Net income (reported basis) | 554 k USD | -54.84 m USD | -62.26 m USD | -94.66 m USD | -122.73 m USD |
| Net income attributable to common shareholders | 554 k USD | -54.84 m USD | -62.26 m USD | — | — |
| Basic earnings per share | 0 USD/share | -0.37 USD/share | -0.45 USD/share | -0.7 USD/share | -1.55 USD/share |
| Diluted earnings per share | 0 USD/share | -0.37 USD/share | -0.45 USD/share | -0.7 USD/share | -1.55 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.